These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28544082)

  • 1. A resource of potential drug targets and strategic decision-making for obstructive sleep apnoea pharmacotherapy.
    Horner RL; Grace KP; Wellman A
    Respirology; 2017 Jul; 22(5):861-873. PubMed ID: 28544082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic approach to pharmacotherapy in the management of obstructive sleep apnoea.
    Aishah A; Eckert DJ
    Curr Opin Pulm Med; 2019 Nov; 25(6):594-601. PubMed ID: 31503212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targets for obstructive sleep apnea pharmacotherapy: principles, approaches, and emerging strategies.
    Horner RL
    Expert Opin Ther Targets; 2023; 27(7):609-626. PubMed ID: 37494064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapies for obstructive sleep apnoea: where are we now?
    Smith IE; Quinnell TG
    Drugs; 2004; 64(13):1385-99. PubMed ID: 15212557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy for obstructive sleep apnoea in adults.
    Smith I; Lasserson TJ; Wright J
    Cochrane Database Syst Rev; 2006 Apr; (2):CD003002. PubMed ID: 16625567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic approaches to obstructive sleep apnoea - New pathways for targeted therapy.
    Eckert DJ
    Sleep Med Rev; 2018 Feb; 37():45-59. PubMed ID: 28110857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological approaches to the treatment of obstructive sleep apnoea.
    Kohler M; Bloch KE; Stradling JR
    Expert Opin Investig Drugs; 2009 May; 18(5):647-56. PubMed ID: 19388881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug therapy for obstructive sleep apnoea in adults.
    Mason M; Welsh EJ; Smith I
    Cochrane Database Syst Rev; 2013 May; (5):CD003002. PubMed ID: 23728641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitfalls of clinical trials on pharmacological treatment for obstructive sleep apnoea: future directions.
    Kohler M; Stradling JR
    Expert Opin Investig Drugs; 2011 Aug; 20(8):1033-7. PubMed ID: 21635196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotyping interindividual variability in obstructive sleep apnoea response to temazepam using ventilatory chemoreflexes during wakefulness.
    Wang D; Marshall NS; Duffin J; Yee BJ; Wong KK; Noori N; Ng SS; Grunstein RR
    J Sleep Res; 2011 Dec; 20(4):526-32. PubMed ID: 21668806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of acute morphine on obstructive sleep apnoea: a randomised double-blind placebo-controlled crossover trial.
    Rowsell L; Wong KKH; Yee BJ; Eckert DJ; Somogyi AA; Duffin J; Grunstein RR; Wang D
    Thorax; 2019 Feb; 74(2):177-184. PubMed ID: 30166422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacotherapy of Apnea by Cannabimimetic Enhancement, the PACE Clinical Trial: Effects of Dronabinol in Obstructive Sleep Apnea.
    Carley DW; Prasad B; Reid KJ; Malkani R; Attarian H; Abbott SM; Vern B; Xie H; Yuan C; Zee PC
    Sleep; 2018 Jan; 41(1):. PubMed ID: 29121334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Therapy in Obstructive Sleep Apnea.
    Hedner J; Zou D
    Sleep Med Clin; 2018 Jun; 13(2):203-217. PubMed ID: 29759271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Qualitative Phenotyping of Obstructive Sleep Apnea and Its Clinical Usefulness for the Sleep Specialist.
    Bosi M; De Vito A; Eckert D; Steier J; Kotecha B; Vicini C; Poletti V
    Int J Environ Res Public Health; 2020 Mar; 17(6):. PubMed ID: 32244892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genioglossus reflex responses to negative upper airway pressure are altered in people with tetraplegia and obstructive sleep apnoea.
    Wijesuriya NS; Gainche L; Jordan AS; Berlowitz DJ; LeGuen M; Rochford PD; O'Donoghue FJ; Ruehland WR; Carberry JC; Butler JE; Eckert DJ
    J Physiol; 2018 Jul; 596(14):2853-2864. PubMed ID: 29658103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotyping the pathophysiology of obstructive sleep apnea using polygraphy/polysomnography: a review of the literature.
    Bosi M; De Vito A; Kotecha B; Viglietta L; Braghiroli A; Steier J; Pengo M; Sorrenti G; Gobbi R; Vicini C; Poletti V
    Sleep Breath; 2018 Sep; 22(3):579-592. PubMed ID: 29318567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea.
    Mason M; Cates CJ; Smith I
    Cochrane Database Syst Rev; 2015 Jul; (7):CD011090. PubMed ID: 26171909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of pharmacotherapy for OSA in adults: A systematic review and network meta-analysis.
    Gaisl T; Haile SR; Thiel S; Osswald M; Kohler M
    Sleep Med Rev; 2019 Aug; 46():74-86. PubMed ID: 31075665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obstructive Sleep Apnea without Obesity Is Common and Difficult to Treat: Evidence for a Distinct Pathophysiological Phenotype.
    Gray EL; McKenzie DK; Eckert DJ
    J Clin Sleep Med; 2017 Jan; 13(1):81-88. PubMed ID: 27655455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An Integrative Model of Physiological Traits Can be Used to Predict Obstructive Sleep Apnea and Response to Non Positive Airway Pressure Therapy.
    Owens RL; Edwards BA; Eckert DJ; Jordan AS; Sands SA; Malhotra A; White DP; Loring SH; Butler JP; Wellman A
    Sleep; 2015 Jun; 38(6):961-70. PubMed ID: 25515107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.